BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 23259710)

  • 21. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: A review.
    Moura PC; Raposo M; Vassilenko V
    Biomed J; 2023 Aug; 46(4):100623. PubMed ID: 37336362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breathomics from exhaled volatile organic compounds in pediatric asthma.
    Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
    Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
    Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
    Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A European Respiratory Society technical standard: exhaled biomarkers in lung disease.
    Horváth I; Barnes PJ; Loukides S; Sterk PJ; Högman M; Olin AC; Amann A; Antus B; Baraldi E; Bikov A; Boots AW; Bos LD; Brinkman P; Bucca C; Carpagnano GE; Corradi M; Cristescu S; de Jongste JC; Dinh-Xuan AT; Dompeling E; Fens N; Fowler S; Hohlfeld JM; Holz O; Jöbsis Q; Van De Kant K; Knobel HH; Kostikas K; Lehtimäki L; Lundberg J; Montuschi P; Van Muylem A; Pennazza G; Reinhold P; Ricciardolo FLM; Rosias P; Santonico M; van der Schee MP; van Schooten FJ; Spanevello A; Tonia T; Vink TJ
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
    Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of some pulmonary diseases in exhaled breath.
    Kharitonov SA; Barnes PJ
    Biomarkers; 2002; 7(1):1-32. PubMed ID: 12101782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis.
    Fan X; Zhong R; Liang H; Zhong Q; Huang H; He J; Chen Y; Wang Z; Xie S; Jiang Y; Lin Y; Chen S; Liang W; He J
    BMC Cancer; 2024 Jun; 24(1):775. PubMed ID: 38937687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential role of exhaled breath analysis in the diagnostic process of pneumonia-a systematic review.
    van Oort PM; Povoa P; Schnabel R; Dark P; Artigas A; Bergmans DCJJ; Felton T; Coelho L; Schultz MJ; Fowler SJ; Bos LD
    J Breath Res; 2018 Feb; 12(2):024001. PubMed ID: 29292698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.
    Robroeks CM; van Berkel JJ; Jöbsis Q; van Schooten FJ; Dallinga JW; Wouters EF; Dompeling E
    Eur Respir J; 2013 Jul; 42(1):98-106. PubMed ID: 23645402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exhaled breath testing - A tool for the clinician and researcher.
    Davis MD; Fowler SJ; Montpetit AJ
    Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.